Australian Whisky Holdings (ASX:AWY) appointments
04 Oct 2019 - Australian Whisky Holdings (ASX:AWY) has appointed Geoff Bainbridge and David Dearie to executive director roles effective immediately.
04 Oct 2019 - Australian Whisky Holdings (ASX:AWY) has appointed Geoff Bainbridge and David Dearie to executive director roles effective immediately.
04 Oct 2019 - Briscoe Group Australasia (ASX:BGP) has announced its support for the Kathmandu Holdings (ASX:KMD) capital raising.
04 Oct 2019 - Medical cannabis producer, supplier and exporter Althea Group Holdings (ASX:AGH) has seen a record month for patient uptake in September.
04 Oct 2019 - Digital health company, ResApp Health (ASX:RAP) has been selected to join the Startup Creasphere Digital Health Program in Munich.
04 Oct 2019 - GetSwift’s (ASX:GSW) US-based subsidiary GetSwift Inc. has signed a Teaming Agreement with Patriot Defense Group LLC.
04 Oct 2019 - The ASX is set to open 0.5% higher and unwind some of yesterday’s losses. The expected rally follows speculation that the US Federal Bank may effect a third rate cut for the year at its October policy meeting. Alan Dixon has resigned from wealth management company, Evans Dixon (ASX:ED1) overnight.
03 Oct 2019 - It has been a disappointing day of trade for the ASX. After opening in the black the local bourse failed to gain momentum to close 2.2% lower. Ooh!Media (ASX:OML) dropped today as did Nearmap (ASX:NEA). As for the sectors, Utilities lost the least and Telcos came in bottom of the pile. And Probiotec (ASX:PBP) has today completed the sale of the Celebrity Slim brand.
03 Oct 2019 - The ASX dropped at the open and is now 2.1% lower at noon. The four big banks all dropped. Agribusiness Webster (ASX:WBA) shares shot up today after news they have been approached by a Canadian pension fund with a takeover bid worth $854 million. And Agrimin (ASX:AMN) has awarded Kerman Contracting the engineering design contract for the Wyndham Port Facility.
03 Oct 2019 - Leading agricultural firm Webster (ASX:WBA) has signed a binding agreement to be acquired by Canadian pension fund giant PSP Investments.
03 Oct 2019 - Leader in cellular medicines for inflammatory diseases, Mesoblast (ASX:MSB) has successfully completed a $75 million capital raising.